Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230221003
TCTR20230221003
Completed
Phase 4

A Randomized Controlled Trial Comparing the Diagnostic Yield of using Rapid On-Site Cytology Evaluation (ROSE) and without using ROSE in Radial Probe Endobronchial Ultrasound (R-EBUS) Guided Sheath Transbronchial Lung Biopsy with Bronchial Brushing in Peripheral Pulmonary Lesions.

King Chulalongkorn Memorial hospital0 sites68 target enrollmentFebruary 21, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAll patients over the age of 18 who have been scheduled for bronchoscope to get the tissue diagnosis from the peripheral lung lesions at the pulmonary unit, Chulalongkorn HospitalRapid on-site cytology evaluation (ROSE), Radial Probe endobronchial ultrasound (RP-EBUS), Transbronchial lung biopsy, Peripheral pulmonary lung lesion, Bronchial brushing, Bronchus sign

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
All patients over the age of 18 who have been scheduled for bronchoscope to get the tissue diagnosis from the peripheral lung lesions at the pulmonary unit, Chulalongkorn Hospital
Sponsor
King Chulalongkorn Memorial hospital
Enrollment
68
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 21, 2023
End Date
November 30, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. All patients over 18 years old
  • •2\.All patients diagnosed with peripheral lung lesions or nodule size smaller than or equal to 3 centimeters from chest computed tomography.

Exclusion Criteria

  • •Patients who have bronchoscopy contraindications
  • •\-No consent for the procedure
  • •\-Patients do not cooperate during the procedure.
  • •\-Risk of hemorrhagic conditions such as Severe Thrombocytopenia (Platelet \<20000\) , Coagulopathy ( INR \< 2\) that have not been resolved.
  • •\-Severe or refractory hypoxia (SpO2 \< 90%)
  • •\-Unstable Hemodynamic Status : BP \<90/60, MAP \< 65, HR \< 50 or \> 130, RR\>30
  • •\-Myocardial Infarction within 4\-6 weeks
  • •\-Patients who increased intracranial pressure
  • •\-Severe pulmonary arterial hypertension
  • •\-Other relative contraindication conditions depend on judgement of doctor, such as uremia and Superior Vena Cava Obstruction.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Maintenance Of Extraction Socket Dimensions With Bone Graft And Proteins Extracted from Blood For Future Implant PlacementHealth Condition 1: null- patients undergoing tooth extraction and require replacement of missing tooth
CTRI/2017/09/009781A Dedeepya27
Recruiting
Phase 3
A clinical trial intended to compare the treatment effect of two antituberculosis regimens, daily and intermittent regimens in HIV patients with Pulmonary TB.Health Condition 1: null- culture positive Pulmonary Tuberculosis in HIV
CTRI/2009/091/000476Tuberculosis Research Centre ICMR420
Completed
Phase 1
Study comparing the effect of pain relief provided by one combination of drug(Ketofol) with that of the other(Etofen)
CTRI/2019/01/017329Department of Emergency Medicine Bangalore Baptist Hospital Bellary road Hebbal Bangalore108
Not yet recruiting
Not Applicable
Comparison of two different ultrasound techniques for cooled radiofrequency ablation treatment of knee osteoarthritis
CTRI/2022/11/047701ady Hardinge Medical College
Not yet recruiting
Phase 4
A trial to see which form of the drug Misoprostol used for induction of labour is more effective and safer- in fluid form given at regular intervals starting at low dose or as a tablet with fixed dose.
CTRI/2023/03/051096Rajagiri Hospital